Abstract:Bioinformatics has emerged as a valuable tool for screening drugs and understanding their effects. This systematic review aimed to evaluate whether in silico studies using anti-obesity peptides targeting therapeutic pathways for obesity, when subsequently evaluated in vitro and in vivo, demonstrated effects consistent with those predicted in the computational analysis. The review was framed by the question: "What peptides or proteins have been used to treat obesity in in silico studies?" and structured according to the acronym PECo. The systematic review protocol was developed and registered in PROSPERO (CRD42022355540) in accordance with the PRISMA-P, and all stages of the review adhered to these guidelines. Studies were sourced from the following databases: PubMed, ScienceDirect, Scopus, Web of Science, Virtual Heath Library, and EMBASE. The search strategies resulted in 1015 articles, of which, based on the exclusion and inclusion criteria, 7 were included in this systematic review. The anti-obesity peptides identified originated from various sources including bovine alpha-lactalbumin from cocoa seed (Theobroma cacao L.), chia seed (Salvia hispanica L.), rice bran (Oryza sativa), sesame (Sesamum indicum L.), sea buckthorn seed flour (Hippophae rhamnoides), and adzuki beans (Vigna angularis). All articles underwent in vitro and in vivo reassessment and used molecular docking methodology in their in silico studies. Among the studies included in the review, 46.15% were classified as having an "uncertain risk of bias" in six of the thirteen criteria evaluated. The primary target investigated was pancreatic lipase (n = 5), with all peptides targeting this enzyme demonstrating inhibition, a finding supported both in vitro and in vivo. Additionally, other peptides were identified as PPARγ and PPARα agonists (n = 2). Notably, all peptides exhibited different mechanisms of action in lipid metabolism and adipogenesis. The findings of this systematic review underscore the effectiveness of computational simulation as a screening tool, providing crucial insights and guiding in vitro and in vivo investigations for the discovery of novel anti-obesity peptides.

Bioinformatics tools for the study of bioactive peptides from vegetal sources: evolution and future perspectives

Bioactive Peptides of Plant Origin: Distribution, Functionality, and Evidence of Benefits in Food and Health

BioPepDB: an Integrated Data Platform for Food-Derived Bioactive Peptides.

Screening of Novel Bioactive Peptides from Goat Casein: In Silico to In Vitro Validation

Recent advancement in functional properties and toxicity assessment of plant-derived bioactive peptides using bioinformatic approaches

The Search for Peptide-Based Therapeutics Using Computational Tools

Bioactive peptides against angiotensin‐converting enzyme I: An in silico study

Challenges in computational discovery of bioactive peptides in 'omics data

The current research status and strategies employed to modify food-derived bioactive peptides

Recent Advances and Computational Approaches in Peptide Drug Discovery

Emerging production techniques and potential health promoting properties of plant and animal protein-derived bioactive peptides

Bioinformatics Approaches Applied to the Discovery of Antifungal Peptides

Production and Functionality of Food-derived bioactive peptides: A review.

From Natural Sources to Therapeutics

Hybrid Strategy of Bioinformatics Modeling (in silico): Biologically Active Peptides of Milk Protein

Peptides Evaluated In Silico, In Vitro, and In Vivo as Therapeutic Tools for Obesity: A Systematic Review

Recent research progress of biologically active peptides

Bioactive Peptides from Algae: Traditional and Novel Generation Strategies, Structure-Function Relationships, and Bioinformatics as Predictive Tools for Bioactivity

Peptipedia v2.0: A peptide sequence database and user-friendly web platform. A major update

Recent Advancements in Novel Bioactive Peptides and Protein Hydrolysates Isolated from Different Medicinal Plants Along with Their Applications in Food and Pharmaceutical Industries

COMPUTATIONAL APPROACHES FOR DRUG DISCOVERY FROM MEDICINAL PLANTS IN THE ERA OF DATA DRIVEN RESEARCH